Medicine and Dentistry
Cell-Free DNA
75%
Cerebrospinal Fluid
25%
Droplet Digital Polymerase Chain Reaction
100%
Ganglioneuroblastoma
100%
Hodgkin's Lymphoma
25%
Intracranial Tumor
25%
Kidney Tumour
25%
Liquid Biopsy
100%
Messenger RNA
50%
Minimal Residual Disease
25%
Neoplasm
50%
Patient with Neuroblastoma
50%
Pediatric Cancer
50%
Pediatrics
100%
Rhabdomyosarcoma
25%
Solid Malignant Neoplasm
100%
Treatment Response
25%
Tumor Marker
50%
Tumor Suppressor Gene
25%
Wilms' Tumor
50%
Keyphrases
Blood mRNA
11%
Blood Samples
11%
Bone Marrow
11%
Brain Tumor
11%
Cell-free DNA (cfDNA)
22%
Cerebrospinal Fluid
11%
Clinical Outcomes
11%
DNA Pools
11%
Droplet Digital PCR (ddPCR)
100%
Healthy Adults
11%
High Risk
11%
High-risk Neuroblastoma
11%
Hodgkin Lymphoma
11%
Hypermethylation
22%
Large Cohort
11%
Liquid Biopsy
100%
Metastatic Neuroblastoma
22%
Minimal Residual Disease
11%
Nephroblastoma
22%
Neuroblastoma
33%
Pan-cancer
11%
Pediatric
11%
Pediatric Tumors
100%
Plasma Samples
11%
Polymerase Chain Reaction Assay
22%
RASSF1A
100%
Reaction-based
11%
Renal Tumor
11%
Rhabdomyosarcoma
11%
Serum Tumor Markers
11%
Total Cell-free DNA
11%
Treatment Monitoring
11%
Tumor
11%
Tumor DNA
11%
Tumor Marker
11%
Tumor Subtype
11%
Tumor Suppressor Gene
11%
Working Diagnosis
11%